Full Year
Full Year
Exor’s Board of Directors approves 2021 results
The Exor Board of Directors’ meeting, chaired by John Elkann, approved today the 2021 Annual Report, which will be submitted for adoption to the Annual General Meeting of Shareholders on 24 May 2022.
EXOR’S BOARD OF DIRECTORS APPROVES 2020 RESULTS
The Exor Board of Directors’ meeting, chaired by John Elkann, approved the 2020 Annual Report, which will be submitted for adoption to the Annual General Meeting of Shareholders on 27 May 2021.
Exor’s Board of Directors approves 2019 results
The EXOR Board of Directors’ meeting, chaired by John Elkann, approved the 2019 Annual Report, which will be submitted for adoption to the Annual General Meeting of Shareholders on 20 May 2020.
EXOR’s Board of Directors approves 2018 results
The EXOR Board of Directors’ meeting, chaired by John Elkann, met today in Amsterdam and approved the 2018 Annual Report, which will be submitted for adoption to the Shareholders’ Annual General Meeting set for the date of 29 May 2019.
NAV
At 31 December 2018 EXOR’s NAV was $19,740 million, a decrease of $3,232 million (-14.1%), compared to $22,972 million at 31 December 2017. At 31 December 2018 the NAV per share was $82.33, a decrease of $13 per share (-13.6%), compared to $95.32 at 31 December 2017.